110 related articles for article (PubMed ID: 16641922)
21. Guanidino compound metabolism in rats subjected to 20% to 90% nephrectomy.
Levillain O; Marescau B; de Deyn PP
Kidney Int; 1995 Feb; 47(2):464-72. PubMed ID: 7536856
[TBL] [Abstract][Full Text] [Related]
22. Biochemical and histopathological changes in nephrectomized mice.
Al Banchaabouchi M; Marescau B; D'Hooge R; Van Marck E; Van Daele A; Levillain O; De Deyn PP
Metabolism; 1998 Mar; 47(3):355-61. PubMed ID: 9500577
[TBL] [Abstract][Full Text] [Related]
23. Long-term effect of partial nephrectomy on biological parameters, kidney histology, and guanidino compound levels in mice.
Al Banchaabouchi M; Marescau B; Van Marck E; D'hooge R; De Deyn PP
Metabolism; 2001 Dec; 50(12):1418-25. PubMed ID: 11735086
[TBL] [Abstract][Full Text] [Related]
24. Dietary n-3 polyunsaturated fatty acids or soy protein isolate did not attenuate disease progression in a female rat model of autosomal recessive polycystic kidney disease.
Maditz KH; Oldaker C; Nanda N; Benedito V; Livengood R; Tou JC
Nutr Res; 2014 Jun; 34(6):526-34. PubMed ID: 25026920
[TBL] [Abstract][Full Text] [Related]
25. Guanidino compounds in uraemic dialysed patients.
De Deyn P; Marescau B; Lornoy W; Becaus I; Lowenthal A
Clin Chim Acta; 1986 Jun; 157(2):143-50. PubMed ID: 3719996
[TBL] [Abstract][Full Text] [Related]
26. Significance of guanidino compounds in non-dialyzed patients with chronic renal failure.
Ikezaki N
Nihon Jinzo Gakkai Shi; 1990 Mar; 32(3):283-90. PubMed ID: 2355664
[TBL] [Abstract][Full Text] [Related]
27. Altered organic anion and osmolyte content and excretion in rat polycystic kidney disease: an NMR study.
Ogbron MR; Sareen S; Prychitko J; Buist R; Peeling J
Am J Physiol; 1997 Jan; 272(1 Pt 2):F63-9. PubMed ID: 9039050
[TBL] [Abstract][Full Text] [Related]
28. Citrate therapy for polycystic kidney disease in rats.
Tanner GA; Tanner JA
Kidney Int; 2000 Nov; 58(5):1859-69. PubMed ID: 11044205
[TBL] [Abstract][Full Text] [Related]
29. Guanidino compounds in serum and cerebrospinal fluid of non-dialyzed patients with renal insufficiency.
De Deyn PP; Marescau B; Cuykens JJ; Van Gorp L; Lowenthal A; De Potter WP
Clin Chim Acta; 1987 Jul; 167(1):81-8. PubMed ID: 3665089
[TBL] [Abstract][Full Text] [Related]
30. Plasma, urinary, and erythrocyte concentrations of guanidino compounds in patients with chronic renal failure.
Tanaka A; Takahashi Y; Mizokuchi M; Shimada N; Koide H
Ren Fail; 1999 Sep; 21(5):499-514. PubMed ID: 10516995
[TBL] [Abstract][Full Text] [Related]
31. Potassium citrate/citric acid intake improves renal function in rats with polycystic kidney disease.
Tanner GA
J Am Soc Nephrol; 1998 Jul; 9(7):1242-8. PubMed ID: 9644634
[TBL] [Abstract][Full Text] [Related]
32. Convulsive action and toxicity of uremic guanidino compounds: behavioral assessment and relation to brain concentration in adult mice.
D'Hooge R; Pei YQ; Marescau B; De Deyn PP
J Neurol Sci; 1992 Oct; 112(1-2):96-105. PubMed ID: 1469446
[TBL] [Abstract][Full Text] [Related]
33. Improved Gas Chromatographic Determination of Guanidino Compounds Using Isovaleroylacetone and Ethyl Chloroformate as Derivatizing Reagents.
Zounr RA; Khuhawar MY; Jahangir TM; Alamgir M
Anal Sci; 2016; 32(2):141-6. PubMed ID: 26860556
[TBL] [Abstract][Full Text] [Related]
34. Two non-invasive GFR-estimation methods in rat models of polycystic kidney disease: 3.0 Tesla dynamic contrast-enhanced MRI and optical imaging.
Sadick M; Attenberger U; Kraenzlin B; Kayed H; Schoenberg SO; Gretz N; Schock-Kusch D
Nephrol Dial Transplant; 2011 Oct; 26(10):3101-8. PubMed ID: 21444361
[TBL] [Abstract][Full Text] [Related]
35. Transcriptome analysis of a rat PKD model: Importance of genes involved in extracellular matrix metabolism.
Riera M; Burtey S; Fontés M
Kidney Int; 2006 May; 69(9):1558-63. PubMed ID: 16541020
[TBL] [Abstract][Full Text] [Related]
36. [Guanidino compounds and aliphatic monoamines in acute and chronic renal failure].
Suzuki Y
Nihon Jinzo Gakkai Shi; 1992 Oct; 34(10):1077-85. PubMed ID: 1289608
[TBL] [Abstract][Full Text] [Related]
37. Mesenchymal Stromal Cells Improve Renovascular Function in Polycystic Kidney Disease.
Franchi F; Peterson KM; Xu R; Miller B; Psaltis PJ; Harris PC; Lerman LO; Rodriguez-Porcel M
Cell Transplant; 2015; 24(9):1687-98. PubMed ID: 25290249
[TBL] [Abstract][Full Text] [Related]
38. The biosynthesis of guanidinosuccinic acid by perfused rat liver.
Perez G; Rey A; Schiff E
J Clin Invest; 1976 Mar; 57(3):807-9. PubMed ID: 1249211
[TBL] [Abstract][Full Text] [Related]
39. Metabolism of arginine by the isolated perfused rat kidney.
Perez GO; Epstein M; Rietberg B; Loutzenhiser R
Am J Physiol; 1978 Oct; 235(4):F376-80. PubMed ID: 696875
[TBL] [Abstract][Full Text] [Related]
40. Dietary conjugated linoleic acid reduces PGE2 release and interstitial injury in rat polycystic kidney disease.
Ogborn MR; Nitschmann E; Bankovic-Calic N; Weiler HA; Fitzpatrick-Wong S; Aukema HM
Kidney Int; 2003 Oct; 64(4):1214-21. PubMed ID: 12969139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
